RhumbLine Advisers’s Chemomab Therapeutics CMMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.8K Buy
18,366
+510
+3% +$871 ﹤0.01% 3677
2025
Q4
$29.5K Buy
17,856
+8,351
+88% +$22.2K ﹤0.01% 3719
2025
Q3
$25K Sell
9,505
-464
-5% -$1.71K ﹤0.01% 3751
2025
Q2
$46.2K Buy
9,969
+4,007
+67% +$19.8K ﹤0.01% 3677
2025
Q1
$26K Buy
5,962
+10
+0.2% +$70 ﹤0.01% 3697
2024
Q4
$43.1K Sell
5,952
-941
-14% -$5.94K ﹤0.01% 3682
2024
Q3
$43.3K Buy
6,893
+1,924
+39% +$10.8K ﹤0.01% 3701
2024
Q2
$18.3K Buy
4,969
+312
+7% +$1.08K ﹤0.01% 3885
2024
Q1
$14.5K Hold
4,657
﹤0.01% 3810
2023
Q4
$9.5K Buy
4,657
+3,946
+555% +$10.4K ﹤0.01% 3870
2023
Q3
$2.54K Sell
711
-40
-5% -$187 ﹤0.01% 4089
2023
Q2
$3.94K Buy
+751
New +$4.74K ﹤0.01% 4123

Other funds holding CMMB